Pharmaceutical firm Cipla is all set to launch Favipiravir, developed by the Council of Scientific and Industrial Research (CSIR) in a cost-effective process, for the treatment of COVID-19 patients,...
from NDTV News - Latest https://ift.tt/2ORjxma
via IFTTT
from NDTV News - Latest https://ift.tt/2ORjxma
via IFTTT
Advertisement
